Comprehensive Introduction to Hemostatic Agents in Orthopedics

In the demanding environment of modern orthopedic surgery, achieving rapid and reliable hemostasis is paramount. Hemorrhage control is not merely a matter of convenience; it is a critical component of patient safety, visibility in the surgical field, and the reduction of postoperative complications such as hematomas. Surgicel (oxidized regenerated cellulose) and its variant, Fibrillar, represent the gold standard in topical absorbable hemostatic agents.

These devices are engineered to interact with the body’s natural coagulation cascade, providing a scaffold for clot formation while remaining fully biocompatible. In orthopedic procedures—ranging from complex spinal fusion to total joint arthroplasty—these agents provide the precision required to control capillary, venous, and small arterial bleeding where conventional methods like suturing or electrocautery may be impractical or risky.

Deep-Dive: Technical Specifications and Mechanisms of Action

Understanding the material science behind Surgicel and Fibrillar is essential for the orthopedic surgeon. These products are derived from plant-based cellulose, which is processed to create a porous, absorbable matrix.

The Mechanism of Action

The hemostatic effect of Surgicel is primarily physical and chemical. Upon contact with blood, the cellulose matrix:
1. Forms a Gelatinous Mass: It absorbs blood, swelling to create a physical barrier that conforms to the irregular surfaces of bone or soft tissue.
2. Lowers pH: The acidic environment created by the oxidized regenerated cellulose (ORC) has a localized bactericidal effect, which is highly beneficial in preventing surgical site infections (SSI).
3. Platelet Aggregation: The physical structure provides a framework for platelet adhesion and fibrin deposition, accelerating the natural clotting process.

Comparative Technical Specifications

Biomechanics and Tissue Interaction

Unlike mechanical clips or screws, Surgicel Fibrillar is designed to be "pliable." In orthopedic applications, especially in the vertebral canal or near neural structures, the ability to pack a hemostatic agent without applying excessive mechanical pressure is a biomechanical advantage. It exerts minimal mass effect, reducing the risk of nerve root compression or vascular compromise.

Clinical Indications and Surgical Usage

Hemostatic agents are indicated as an adjunctive device to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

Orthopedic Applications

• Spinal Surgery: Used during laminectomies or discectomies to control epidural venous bleeding. Fibrillar is particularly useful here due to its conformability.
• Joint Arthroplasty: Utilized in the management of bleeding from the cancellous bone surfaces after the preparation of the femoral or tibial canal.
• Trauma/Fracture Fixation: Applied to soft tissue sites surrounding complex fractures to minimize the formation of dead space hematomas.
• Pediatric Orthopedics: Preferred in delicate reconstructive surgeries where minimizing blood loss is vital for patient stability.

Proper Application Technique

1. Preparation: Ensure the surgical site is as dry as possible of excess pooled blood.
2. Application: Use dry forceps to apply the material. For Fibrillar, the layers can be peeled to match the depth and volume of the bleeding site.
3. Pressure: Apply gentle, sustained pressure for 1–2 minutes. The material should not be rubbed, as this may disrupt the initial fibrin scaffold.
4. Volume Control: Use only the minimum amount required to achieve hemostasis. Excess material does not enhance the effect and may lead to a foreign body reaction.

Risks, Side Effects, and Contraindications

While Surgicel and Fibrillar are exceptionally safe, they are not without risks. Proper clinical judgment is required to mitigate potential complications.

Contraindications

• Intravascular Use: Must never be used as a plug for a bleeding vessel lumen, as it can cause embolization.
• Neural Compression: In areas such as the spinal canal, the material swells upon contact with blood. If used in excess, it can expand and cause neural compression, leading to paralysis or pain.
• Infected Sites: Should be used with caution in the presence of active, purulent infections, as the material can act as a nidus for bacteria if not handled correctly.

Potential Side Effects

• Foreign Body Granuloma: Rare, but can occur if excessive material is left in the site.
• Allergic Reactions: Hypersensitivity to cellulose is extremely rare but must be documented if a patient has a known history of cellulose sensitivity.
• Delayed Healing: If packed too tightly, the material can interfere with the natural tissue-to-bone integration process.

Maintenance and Sterilization Protocols

Surgicel/Fibrillar products are supplied as sterile, single-use devices.
* Storage: Store in a cool, dry place. Exposure to moisture can compromise the structural integrity of the cellulose fibers before use.
* Sterilization: These devices are sterilized via ethylene oxide or gamma irradiation. They cannot be re-sterilized by the hospital. If a package is opened and not used, it must be discarded.
* Handling: Always handle with dry, sterile gloves. Contact with wet gloves will cause the material to begin its degradation process prematurely.

Frequently Asked Questions (FAQ)

1. Is Surgicel Fibrillar better than the original Surgicel?

"Better" is subjective; it depends on the application. Fibrillar is more conformable and easier to layer into deep, irregular orthopedic voids, whereas the original Surgicel is superior for surface coverage and suture line reinforcement.

2. Does Surgicel interfere with bone healing?

When used in moderate amounts, it is fully absorbed and does not interfere with osteoblast activity. Excessive packing, however, can create a physical barrier that potentially delays osseous integration.

3. Can I use Surgicel to stop arterial bleeding?

No. Surgicel is indicated for capillary, venous, and small arterial bleeding. It is not designed to control high-pressure arterial hemorrhage.

4. How long does the material take to absorb?

Typically, the material is absorbed within 7 to 14 days, depending on the site of application and the patient's vascularity.

5. Why does the material turn black when applied?

The color change is a normal chemical reaction as the cellulose interacts with hemoglobin. It is a sign that the material is working.

6. Is it safe to leave in the spinal canal?

Yes, but only in minimal amounts. Because the material expands as it absorbs blood, surgeons must exercise extreme caution to avoid neural compression.

7. What should I do if I use too much?

If an excess is identified during surgery, it should be removed via suction or irrigation. Once the wound is closed, the body will eventually absorb it, but the risk of inflammatory reaction increases with the volume of material.

8. Does it have antibacterial properties?

Yes. The low pH of the oxidized regenerated cellulose creates an environment that has been shown in clinical studies to inhibit the growth of common surgical pathogens.

9. Can it be used in patients with bleeding disorders?

It can be used as an adjunct, but it will not replace the need for systemic correction of coagulopathies (e.g., factor replacement or platelet infusion).

10. How should it be stored in the operating room?

It should be kept in its original foil packaging until the exact moment of use to prevent atmospheric moisture from affecting the product's performance.

Patient Outcome Improvements

The integration of advanced hemostatic agents like Surgicel and Fibrillar into orthopedic protocols has significantly improved patient outcomes. By reducing the need for aggressive cauterization, surgeons preserve more delicate soft tissue, which leads to faster recovery times and reduced pain. Furthermore, the reduction in postoperative hematomas decreases the risk of secondary infections and the need for revision surgeries.

In the context of value-based care, these devices are highly cost-effective. While they represent a line-item cost in the surgical supply list, the savings generated by reduced operative time, lower blood transfusion rates, and fewer readmissions for hematoma evacuation make them an essential tool in the modern orthopedic armamentarium.

Surgeons are encouraged to maintain proficiency in the application techniques of these agents, as the "less is more" philosophy remains the gold standard for achieving optimal hemostasis without compromising the biological environment of the surgical site.